Natera Inc

NASDAQ:NTRAUnited States

Natera, Inc. is a diagnostics company, which is focused on the development and commercialization of molecular testing services, applying its technology in the fields of women’s health, oncology and organ health. Its cell-free deoxyribonucleic acid (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The Company's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening, Spectrum Preimplantation Genetics, Anora Miscarriage Test, Empower, and Prospera. The Company also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology. Its NIPT screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother.

Contact Information

Headquarters

13011 MCCALLEN PASS BUILDING A SUITE 100AUSTIN, TX, United States 78753

Phone

650-249-9090

Fax

302-674-5266

Executives

Executive Chairman of the Board, Co-Founder

Matthew Rabinowitz

President, Chief Business Officer

John Fesko

Chief Executive Officer, Director

Steven Chapman

Co-Founder, Director

Jonathan Sheena

Chief Financial Officer

Michael Brophy